These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 4409090

  • 1. [Cryoprecipitation and dextran precipitation in obtaining factor VIII concentrates: results of redetecting antihemophilic globulin A in a patient].
    Kubel M, Wegner H, Liebe S.
    Z Gesamte Inn Med; 1974 Mar 15; 29(6):236-40. PubMed ID: 4409090
    [No Abstract] [Full Text] [Related]

  • 2. [Cryoprecipitation and dextran precipitation in obtaining factor VIII concentrates: comparative protein chemical studies].
    Liebe S, Kubel M, Wegner H.
    Z Gesamte Inn Med; 1974 Mar 15; 29(6):232-6. PubMed ID: 4409089
    [No Abstract] [Full Text] [Related]

  • 3. [New preparation of antihemophilic globulin (factor VIII) obtained by means of cryoprecipitation and the use of dextran].
    Lopaciuk S, Naleczyńska A, Daszyński J, Klenowska Z.
    Acta Haematol Pol; 1971 Mar 15; 2(2):103-8. PubMed ID: 5161830
    [No Abstract] [Full Text] [Related]

  • 4. [Preparatory procedures for obtaining antihemolytic globulin (factor VIII) by the cryoprecipitation method and its various properties].
    Lopaciuk S, Naleczyńska A, Klenowska Z, Daszyński J, Pawelski S.
    Pol Tyg Lek; 1969 Jun 02; 24(22):826-9. PubMed ID: 5802316
    [No Abstract] [Full Text] [Related]

  • 5. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM, Skinner SF, Kaneko JJ.
    Am J Vet Res; 1975 Apr 02; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [Abstract] [Full Text] [Related]

  • 6. Preparation of and clinical experience with antihemophilic factor concentrates.
    Johnson AJ, Karpatkin MH, Newman J.
    Thromb Diath Haemorrh Suppl; 1968 Apr 02; 35():49-59. PubMed ID: 5317364
    [No Abstract] [Full Text] [Related]

  • 7. [in vivo reappearance of injected cryoprecopitate (factor VIII concentrates) in patients with hemophilia A].
    Kuble M, Wegner H, Cron D.
    Z Gesamte Inn Med; 1973 Oct 15; 28(20):608-14. PubMed ID: 4767194
    [No Abstract] [Full Text] [Related]

  • 8. [Studies on cryoprecipitates. 1. Distribution of antihemophilic globulin A (factor VIII) and of thrombocytes in cryoprecipitation].
    Uteg KH, Sander W.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972 Oct 15; 97(4):322-31. PubMed ID: 4116124
    [No Abstract] [Full Text] [Related]

  • 9. Human factor VIII prepared by cryoprecipitation.
    Masure R.
    Vox Sang; 1969 Jan 15; 16(1):1-9. PubMed ID: 5766099
    [No Abstract] [Full Text] [Related]

  • 10. Enhanced yield of antihemophilic factor and von Willebrand factor by cryoprecipitation with polyethylene glycol.
    Johnson AJ, Macdonald VE, Brind J.
    Vox Sang; 1979 Jan 15; 36(2):72-6. PubMed ID: 313629
    [Abstract] [Full Text] [Related]

  • 11. Accumulated antihemophilic globulin.
    Schumacher HR, Rismiller RW, Wetzler WH.
    N Engl J Med; 1970 Dec 10; 283(24):1346. PubMed ID: 5478460
    [No Abstract] [Full Text] [Related]

  • 12. Cryoprecipitate therapy in haemophilia.
    Forbes CD, Hunter J, Barr RD, Davidson JF, Short DW, McDonald GA, McNicol GP, Wallace J, Douglas AS.
    Scott Med J; 1969 Jan 10; 14(1):1-9. PubMed ID: 5304824
    [No Abstract] [Full Text] [Related]

  • 13. Use of aliphatic amino acid precipitated antihemophilic factor in therapy of hemophilia.
    Brinkhous KM, Wagner RH, Roberts HR, Webster WP.
    Bibl Haematol; 1968 Jan 10; 29():1104-8. PubMed ID: 5700305
    [No Abstract] [Full Text] [Related]

  • 14. Acquired circulating anticoagulants in hemophilia A.
    Strauss HS.
    N Engl J Med; 1969 Oct 16; 281(16):866-73. PubMed ID: 5812255
    [No Abstract] [Full Text] [Related]

  • 15. Glycine-precipitated antihemophilic factor concentrates and their clinical use.
    Wagner RH, Roberts HR, Webster WP, Shanbrom E, Brinkhous KM.
    Thromb Diath Haemorrh Suppl; 1968 Oct 16; 35():41-8. PubMed ID: 5761073
    [No Abstract] [Full Text] [Related]

  • 16. Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma.
    Ratnoff OD, Kass L, Lang PD.
    J Clin Invest; 1969 May 16; 48(5):957-62. PubMed ID: 5780204
    [Abstract] [Full Text] [Related]

  • 17. The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma: characterization and further data on preparation and clinical trial.
    Hershgold EJ, Pool JG, Pappenhagen AR.
    J Lab Clin Med; 1966 Jan 16; 67(1):23-32. PubMed ID: 5321736
    [No Abstract] [Full Text] [Related]

  • 18. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
    Duckert F, Müller G, Meili EO.
    Schweiz Med Wochenschr; 1971 Dec 18; 101(50):1831-8. PubMed ID: 5173501
    [No Abstract] [Full Text] [Related]

  • 19. [Production of an enriched factor VIII reagent].
    Bukurestliev A, Angelova Z, Lissitschkov T.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976 Dec 18; 103(5):742-5. PubMed ID: 64415
    [Abstract] [Full Text] [Related]

  • 20. Treatment of hemophilia with factor VIII concentrates.
    Agarwal MB, Mehta BC.
    Indian J Med Sci; 1980 Sep 18; 34(9):226-30. PubMed ID: 6782019
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.